SCHEMBL13301993

SCHEMBL13301993

C=C(CO)[C@@H]1CC[C@]2(COC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=N)C(C)(COC(C)=O)[C@@H]5CC[C@]43C)[C@@H]12

nearest known ligand 0.70

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SLC10A1 Q14973 2/20 0.70
▸ CA9 Q16790 4/20 0.49
▸ PTGES O14684 1/20 0.48
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ LMNA P02545 2/20 0.45
▸ NT5E P21589 2/20 0.45
▸ USP2 O75604 1/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ TOP2A P11388 1/20 0.45
▸ PTPN1 P18031 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ GPBAR1 Q8TDU6 3/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13301992 0.96 SLC10A1 (0.64) SLC10A1CA9PTGESCA1CA2
SCHEMBL13293148 0.91 SLC10A1 (0.71) SLC10A1CA9PTGESCA1CA2
SCHEMBL13301976 0.90 SLC10A1 (0.57) SLC10A1LMNANT5EUSP2HIF1A
SCHEMBL13301931 0.89 PTGES (0.61) SLC10A1CA9PTGESCA1CA2
SCHEMBL13304150 0.89 SLC10A1 (0.70) SLC10A1CA9PTGESCA1CA2
SCHEMBL13293222 0.87 SLC10A1 (0.66) SLC10A1CA9PTGESCA1CA2
SCHEMBL13910776 0.87 SLC10A1 (0.72) SLC10A1CA9PTGESCA1CA2
SCHEMBL13304147 0.86 SLC10A1 (0.67) SLC10A1CA9PTGESCA1CA2
SCHEMBL13293212 0.83 SLC10A1 (0.61) SLC10A1CA9PTGESCA1CA2
SCHEMBL13293224 0.83 SLC10A1 (0.60) SLC10A1CA9PTGESCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010068668-A1 23-SUBSTITUTED DERIVATIVES OF LUPANE-TYPE PENTACYCLIC TRITERPENOIDS ADVANCED LIFE SCIENCES, INC. (US) 2010-06-17 — — WO disclosed
Send feedback